Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Morphine is ranked among the most addictive substances known, with studies placing it alongside heroin as the most addictive drug. Psychological dependence is complex and protracted, persisting long after physical withdrawal resolves. Relapse rates are estimated as high as 98%, and users commonly experience severe depression, anxiety, and overwhelming drug craving during recovery.
Physical dependence develops readily with repeated administration, sometimes after only a short period of use. Withdrawal produces the prototypical opioid withdrawal syndrome with symptoms including anxiety, perspiration, muscle aches, severe cramping, diarrhea, vomiting, and intense drug craving progressing through distinct stages over 7-12 days. While withdrawal is not typically fatal in otherwise healthy individuals, it is intensely uncomfortable.
Fatal overdose has been reported at oral doses of 0.3-1.5 g and intravenous doses of 100 mg in non-tolerant individuals. In opioid-dependent users, the lethal threshold can be significantly higher due to tolerance. Death typically results from respiratory depression leading to asphyxia. Blood concentration LD50 values have been reported at approximately 0.78 µg/mL in males and 0.98 µg/mL in females.
Constipation is one of the most common side effects, occurring consistently even at typical therapeutic doses due to reduced gut motility.
Chronic use causes hypogonadism and hormone imbalances in the majority of long-term users of both sexes; studies suggest up to 90% of chronic opioid users experience opioid-induced hypogonadism.
Chronic use may suppress immune function and increase susceptibility to infections including pneumonia, tuberculosis, and HIV/AIDS; this immunosuppressive effect is primarily documented in individuals with opioid addiction.
Excess consumption over time can cause changes in synaptic neuroplasticity; these effects are associated with chronic heavy use rather than occasional administration.
Confusion, nightmares, and hallucinations may occur as side effects, though these are not prominently reported at typical doses.
The history of morphine is deeply intertwined with humanity's long relationship with the opium poppy. The earliest documented references to opium-based preparations can be traced to the 3rd century BC, when the Greek philosopher Theophrastus recorded their existence. Some scholars suggest that…
Available for medical use in hospital settings. Utilized for acute and chronic pain management under medical supervision.
Received FDA approval in 1941 for medical use. Classified as a narcotic and designated as a high-risk opioid by regulatory authorities. Multiple pharmaceutical formulations have active patents for extended-release and abuse-deterrent preparations.
13 sources cited